Info

You are currently browsing the Capital Comments weblog archives for the day 8. March 2009.

March 2009
S M T W T F S
    Apr »
1234567
891011121314
15161718192021
22232425262728
293031  

Archive for 8. March 2009

Ford’s CEO Allan Mulally- Cool Under Fire

Mulally was interviewed at the ECO:nomics conference by WSJ reporters.  One has to be impressed with Mulally as he is certainly cool under fire. Just at the  helm of Ford for a little over two years now, he previously ran Boeing, he has done a lot of things right. In my opinion he is still doing things right. With the recent union agreements in place along with the financial reorganization efforts this past week which, no doubt, will be dilutive to existing shareholders risk tolerant investors with a 3-5 year time horizon may be encouraged to nibble here.

At $ 1.70 a share its not a bad long term option but lets see how dilutive this financial re-org is going be over the next short while. Chart-wise the stock is above its prior low but there is nothing compelling from a technical point of view at this point.

See the interview for yourself on Market-Watch here.

Ford Feista- A Global Car - The new Ford Fiesta has been recognized as the “Most Successful Design of 2008” by Fortune China, “Best Car” by Business Week, and awarded “Car of the Year” by What Car? magazine in the UK.

According to the Financial Times Ford Motor moved on Wednesday to bolster its liquidity and avoid a US government bailout by offering to swap up to $10.4bn in debt for equity and cash.

Now, it appears that China wants to be a major player in the global automotive industry. It may be prepared to finance the buy-out of Volvo, a division of Ford (F). The Times is reportingthe Chinese car firm Geely may purchase  the car company that was originally based in Sweden. Volvo is the second largest truck-maker in the world.

Two Stem Cell Stocks

GeronOsiris

Click on the charts to enlarge.

The one area of healthcare the Obama Administration seems to favour is that of stem cell research. Here are two of the leading stem cell research companies. High risk, to be sure, but a breakthrough in this line of medical research could be very beneficial to health-care and financially rewarding for those investors prepared to take the risk.

Suncor - Working the Base

suncor080309.png

Suncor has been building a base since October and despite new market lows has retained support at $22. Recent crossover action by the 60 and 90 day moving averages suggest that an assult on on the $30 break-out level may be imminent. (Click on the chart to enlarge.)

A Closer Look at Copper

Dr. CopperFreePort Copper & Gold

Click on the chart to enlarge.

Copper is a leading economic indicator, after building a short-term base are we ready for liftoff? Note how Freeport is tracking copper.

Disclosure: We own Freeport McMoran in client accounts.

|